TIANYIN PHARMACEUTICAL
TPI
TPI was delisted on the 29th of April, 2016.
9 hedge funds and large institutions have $960K invested in TIANYIN PHARMACEUTICAL in 2015 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
13% more funds holding
Funds holding: 8 → 9 (+1)
31% less capital invested
Capital invested by funds: $1.39M → $960K (-$433K)
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$23.4K |
| 2 |
Renaissance Technologies
New York
|
+$19.1K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$4.39K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$3.8K |
| 5 |
AWM
Avior Wealth Management
Omaha,
Nebraska
|
+$624 |
Top Sellers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$15K |
| 2 |
SIM
Spark Investment Management
New York
|
-$14K |
| 3 |
RIM
Regent Investment Management
Louisville,
Kentucky
|
-$2.07K |
TPI Hedge Fund Activity: Q1 2015 in Review
9 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in TIANYIN PHARMACEUTICAL (TPI) for Q1 2015, worth a combined $960K — down 31% from $1.39M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new TPI positions and 2 closed out — a net gain of 1 holder — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $23.4K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $15K sold.
- 9 institutional investors held TIANYIN PHARMACEUTICAL (TPI) as of Q1 2015, up from 8 in Q4 2014.
- Funds reported $960K of TIANYIN PHARMACEUTICAL stock for Q1 2015, down 31% quarter-over-quarter.
- 3 funds opened new TIANYIN PHARMACEUTICAL positions in Q1 2015 and 2 closed out, a net change of +1 holder.
- The largest TIANYIN PHARMACEUTICAL buyer in Q1 2015 was Citadel Advisors, an estimated $23.4K added.
- The largest TIANYIN PHARMACEUTICAL seller in Q1 2015 was Susquehanna International Group, an estimated $15K sold.
Based on aggregated 13F filings for Q1 2015.